The potential role of BTMs in the prediction of hypocalcemia induced by denosumab in patients with bone metastases.
Latest Information Update: 13 Apr 2020
At a glance
- Drugs Denosumab (Primary)
- Indications Bone metastases
- Focus Biomarker; Pharmacodynamics
- 12 Apr 2020 Status changed from active, no longer recruiting to completed.
- 13 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2016 New trial record